Another study demonstrated that miR-137 and the expression of the CACNAC1 gene could inhibit the hyperphosphorylation of tau proteins and inhibit the progression of Alzheimer’s disease [77]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.